Although it's a relatively rare cancer, multiple myeloma, a disorder of the white (plasma) blood cells, strikes more Americans each year than brain cancer.
City of Hope is committed to beating this difficult disease. We have played a role in nearly every modern treatment for multiple myeloma in use today and we are leaders in national trials evaluating stem cell transplantation for myeloma. We are also the only Southern California member of the Multiple Myeloma Research Consortium, a partnership of some 22 facilities across the country, dedicated to rapidly bringing the most promising new treatments to patients.
Thanks to generous support from the Briskin family, we have created a central organizational structure singularly focused on this challenging disease: the Judy and Bernard Briskin Center for Multiple Myeloma Research within the Hematologic Malignancies Research Institute.
We are committed to aggressively pursuing and encouraging new research, developing new and improved treatments and collaborating with myeloma experts nationally and internationally.
- Kenneth Goldman and Briskin Family Clinical Trials Program – The heart and soul of this effort is the development of new therapies.
- Steven Gordon and Briskin Family Innovation Grant Program – Fosters new ideas, increases collaboration and accelerates progress
- Scientific Advisory Board – A distinguished team of scientists and physicians allied with our efforts